[1]
“Use of Potentially Hepatotoxic Drugs in Liver Cirrhosis Patients: A Review”, JPS, vol. 6, no. 2, pp. 766–771, Jun. 2023, doi: 10.36490/journal-jps.com.v6i2.137.